Tenofovir to Prevent HBV Reactivation

Clinical trial NCT02186574 · UNKNOWN

Trial details

NCT number: NCT02186574
Sponsor: University Health Network, Toronto
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B Lymphoma Non-Hodgkin

Start date: 2015-05-01
Primary completion: 2021-02-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.